Managed Trading Allocation Agreement

1. Parties and Scope

This Agreement is between you (the “Allocator” or “you”) and Neurofund (“Neurofund,” “we,” “us”). It governs only the Managed Trading Allocation product (the “Allocation Service”) and the specific allocations you make through it.

This Agreement is in addition to, and not in substitution for, the Terms of Service and Privacy Policy. Where this Agreement conflicts with the Terms of Service in respect of the Allocation Service, this Agreement prevails.

2. Definitions

• “Allocation” — funds you commit to a specific Strategy operated by Neurofund.
• “Strategy” — an algorithmic trading strategy operated by Neurofund on its exchange accounts.
• “Pooled Strategy” — a Strategy in which the funds of multiple Allocators are pooled and trade as a single position. Your share is tracked pro-rata.
• “Wallet” — your Neurofund-platform account balance, denominated in United States Dollars (USD) for international users and Australian Dollars (AUD) for Australian users.
• “Net Asset Value” or “NAV” — the value of your Allocation at a given point in time, reflecting realised gains, realised losses, fees deducted, and the current mark-to-market of open positions where applicable.
• “High Water Mark” or “HWM” — the highest NAV your Allocation has reached at the end of a fee period, against which performance fees are calculated.

3. Eligibility

To use the Allocation Service you must:

• Hold an active Managed subscription, OR be on an active 7-day free trial (international users); Australian users are not required to hold a Managed subscription to allocate.
• Be at least 18 years of age and have legal capacity to enter into financial contracts in your jurisdiction.
• Not be a resident or citizen of, or located in, a jurisdiction subject to comprehensive sanctions or otherwise restricted by Neurofund’s acceptable use policy.
• Have completed identity verification (KYC) by the time you trigger any withdrawal of Allocation funds, or earlier if your account balance, single deposit, or single transaction reaches USD $5,000 or AUD equivalent.

4. Committing Funds to an Allocation

You may initiate an Allocation through the platform’s allocation interface. The minimum allocation per Strategy is USD $500 (or AUD equivalent). Funds are debited from your Wallet to the selected Strategy at the time of allocation.

Each Strategy publishes its own profile, including: trading focus (e.g. spot, perpetual futures), typical position holding period, historical drawdown range, leverage envelope, and any per-strategy specific fees. You should read the Strategy profile carefully before allocating.

You may hold multiple Allocations across different Strategies. Each Allocation is governed by this Agreement independently.

5. Fees

Fees vary by Neurofund product variant. The fee schedule applicable to your Allocation is displayed before you confirm the allocation and is fixed for the duration of that Allocation unless updated by mutual agreement:

(a) Australian users (managed-fund variant):

• Management Fee: 1.5% per annum on Allocation NAV, accrued daily and deducted from the Allocation balance.
• Performance Fee: 20% of net new profits above the High Water Mark, calculated and deducted at each fee period end.

(b) International users (per-trade variant):

• Per-Trade Fee: deducted from the gross profit of each realised winning trade. Loss-making trades are not subject to a per-trade fee. The exact rate is disclosed on the Strategy profile and on the allocation confirmation screen.

Network/blockchain fees on cryptocurrency deposits and withdrawals, and any third-party on-ramp partner fees (typically 3–5% of card-deposit amount), are charged separately by the relevant third party and are not part of Neurofund’s fee schedule.

6. High Water Mark

For Allocations subject to a performance fee, a High Water Mark is maintained per Allocation. The Performance Fee is charged only on positive return above the HWM since the last fee period in which a Performance Fee was charged, or since the Allocation was opened if no Performance Fee has yet been charged.

If the Allocation NAV is below the HWM at the end of a fee period, no Performance Fee is charged. The Strategy must first recover to the HWM before any further Performance Fee accrues. The HWM is preserved across fee periods and does not reset on capital additions or partial withdrawals.

7. Pooled Strategies and Pro-Rata Share

Some Strategies operate as Pooled Strategies. In a Pooled Strategy, the capital of multiple Allocators is combined and trades as a single position on Neurofund’s exchange account. Your share of the pool’s gain or loss is tracked pro-rata to your contribution.

When you close an Allocation in a Pooled Strategy, your share is released when the pool exits its current position via the Strategy’s normal exit signal (see Section 9). You cannot force the pool to close a position to release your share.

The Strategy profile indicates whether a Strategy is Pooled or operates per-Allocator independent positions.

8. Closing an Allocation

You may initiate closure of an Allocation at any time through the platform. Closure moves the Allocation into a Pending Close state pending the Strategy's next exit; while the Allocation remains in Pending Close you may cancel the closure from the Wallet page and the Allocation will resume as Active. Once funds are released to your Wallet the closure is final and cannot be undone.

On closure:

• If the Strategy has no open position attributable to your Allocation, your Allocation NAV is released to your Wallet immediately.
• If the Strategy has an open position, your funds remain in the Strategy until the next exit signal fires. Your pro-rata share of the position value at the moment of exit is released to your Wallet at that time.
• If the Strategy has not exited within 30 days of your close request, Neurofund will force-close the relevant position component at market in an orderly manner, and your share of the resulting NAV is released to your Wallet.

Any accrued Management Fees and any Performance Fee due to the HWM at closure are deducted before the final amount is released.

9. Trial Period and Managed Lapse

International users on a 7-day free trial may open Allocations during the trial. If the trial ends and you do not hold an active Managed subscription, your Allocation enters a 7-day grace period during which:

• The Allocation continues to participate in the Strategy.
• You may subscribe to Managed at any time during the grace period to resume full access and avoid closure.
• You may not add capital to an existing Allocation or open a new Allocation.
• You may close the Allocation manually at any time (subject to Section 8).

If you do not subscribe to Managed within the 7-day grace period, Neurofund will initiate closure of your Allocation under the mechanics described in Section 8. Funds returned to your Wallet at that point remain available to you and may be withdrawn (subject to identity verification and the Terms of Service withdrawal rules) or used to fund future Allocations if you later subscribe to Managed.

Subscription lapse. The same 7-day grace mechanic applies if you are an active paid subscriber (Starter/Pro/Managed) and your subscription fails to renew — that is, both your card on file and your Wallet auto-renew (if enabled) fail to settle the next billing period. We will notify you the moment we detect the lapse. From that point you have 7 days to renew the subscription (via card update or by topping up your Wallet and toggling auto-renew on); after 7 days your Allocations are queued for closure under the same mechanics as a trial-end lapse.

10. Custody of Funds

Fiat balances corresponding to your Wallet and to your Allocation NAV are held at Neurofund’s regulated banking partners and recorded separately from Neurofund’s operating accounts. The specific banking partners may change over time as the platform grows; current providers are disclosed on request.

Funds in active trading positions are held on Neurofund’s execution exchange accounts (currently Bybit and any other exchanges added as the platform grows). Your Allocation NAV reflects your pro-rata claim on the trading account’s capital attributable to the Strategy you are allocated to.

Neurofund does not have an Australian Financial Services Licence (AFSL) at the date this Agreement is published. The Allocation Service is offered on a pre-licence basis. If Neurofund obtains an AFSL or equivalent license in any jurisdiction, this Agreement may be amended to reflect new regulatory requirements with appropriate notice.

11. Reporting

Through the Neurofund platform you have access to:

• Your Allocation NAV, updated as the Strategy trades (subject to exchange data refresh latency).
• A trade-by-trade record of the Strategy’s activity attributable to your Allocation.
• Real-time fee history on the platform showing Management Fees, Performance Fees, and per-trade fees charged against your Allocation.
• An annual activity summary covering the calendar year.

12. Risk Disclosure

13. Wind-Down or Suspension of a Strategy

Neurofund may pause, modify, or permanently wind down a Strategy for reasons including but not limited to: strategy performance deterioration, execution exchange issues, regulatory or legal requirements, or commercial discretion.

If a Strategy is wound down, Neurofund will close all open positions in an orderly manner, calculate final fees, and release the resulting NAV to each affected Allocator’s Wallet. You will be notified before wind-down where reasonably practicable, and in any event no later than the time of wind-down execution.

Where a Strategy is temporarily paused, your Allocation is held without further trading until the Strategy resumes. No new trades are placed during a pause. Management Fees continue to accrue during a pause; if you do not wish to continue, you may close the Allocation under Section 8.

14. No Financial Advice

The Allocation Service is a service offered to you. Neurofund does not provide personal financial, investment, tax, or legal advice. Performance data, Strategy profiles, and any communications about the Allocation Service are general in nature and do not take into account your personal circumstances, financial position, or objectives.

You should obtain independent professional advice as appropriate before committing funds. The decision to allocate, and the choice of Strategy, is yours alone.

15. Taxes

You are responsible for determining and meeting all tax obligations arising from your Allocations in your jurisdiction of residence. Neurofund provides activity records sufficient for typical tax reporting but does not provide tax advice and does not withhold tax on your behalf except where required by law.

16. Termination by Neurofund

Neurofund may terminate this Agreement and close your Allocations, with or without notice, where: (a) you breach this Agreement or the Terms of Service; (b) you fail to complete identity verification when required; (c) screening reveals a sanctions or PEP match that we are required to act on; (d) we are required to do so by applicable law or a competent authority; or (e) we determine in good faith that continued allocation poses an unacceptable risk to Neurofund, the Strategy, or other Allocators.

On termination by Neurofund, your Allocations will be closed under Section 8 mechanics and resulting funds released to your Wallet, subject to withdrawal rules and any legal obligations binding on Neurofund.

17. Limitation of Liability

To the maximum extent permitted by law, Neurofund’s aggregate liability to you under or in connection with this Agreement and the Allocation Service is limited to the total fees paid by you to Neurofund in respect of the relevant Allocation in the 12 months preceding the event giving rise to the claim.

Neurofund is not liable for loss of profit, loss of opportunity, loss of data, consequential loss, or indirect loss of any kind. Nothing in this Agreement excludes or limits liability that cannot be excluded or limited under applicable consumer or financial-services law.

18. Indemnification

You agree to indemnify and hold Neurofund and its officers, directors, employees, and agents harmless from any claims, losses, liabilities, damages, and reasonable expenses arising from your breach of this Agreement, your violation of applicable law, or your use of the Allocation Service in a manner not permitted by this Agreement.

19. Modifications

Neurofund may modify this Agreement from time to time. The current version is shown at the top of this page (see “Version”). Material changes will be notified to you by email and through the platform before they take effect. Continued use of the Allocation Service after the effective date of a change constitutes acceptance. If you do not accept a change, your remedy is to close your Allocations under Section 8 before the change takes effect.

20. Dispute Resolution and Governing Law

Any dispute under this Agreement is first to be raised through Neurofund’s support channel and addressed in good faith. If not resolved within 30 days, the dispute is to be submitted to binding arbitration in the jurisdiction of Neurofund’s principal place of business at the time, in accordance with the applicable arbitration rules of that jurisdiction.

This Agreement is governed by the law of the jurisdiction of Neurofund’s principal place of business, without regard to its conflict-of-laws principles. Mandatory consumer-protection laws of your jurisdiction of residence continue to apply where applicable.

21. Contact

For questions about this Agreement or the Allocation Service, contact us at:

support@neurofund.com.au